Pharmaceuticals, Biotechnology and Life Sciences
NEW HAVEN, Conn., Oct. 22, 2024 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new…
SAN DIEGO, Oct. 22, 2024 (GLOBE NEWSWIRE) — Gyre Therapeutics, Inc. (“Gyre”) (Nasdaq: GYRE), a self-sustainable, commercial-stage biotechnology company with…
SAN DIEGO, Oct. 22, 2024 (GLOBE NEWSWIRE) — Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is…
Acquisition creates a leading, clinical-stage company focused on the development of gene therapy treatments for rare inherited retinal degenerations New…
WALTHAM, Mass., Oct. 22, 2024 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to…
– VIRO-25 trial to assess efficacy & safety of olvimulogene nanivacirepvec (Olvi-Vec) & platinum-doublet + physician’s choice of immune checkpoint…
CARSON CITY, Nev., Oct. 22, 2024 (GLOBE NEWSWIRE) — BioVie Inc. (Nasdaq: BIVI), (“BioVie” or the “Company”), a clinical-stage company…
American Heart Association (AHA) poster to be presented on November 16, 2024WATERTOWN, Mass., Oct. 22, 2024 (GLOBE NEWSWIRE) — Tectonic…
LONDON, Oct. 22, 2024 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a…
LEIDEN, Netherlands & CAMBRIDGE, Mass., Oct. 22, 2024 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq: PRQR) (“ProQR”), a company dedicated to…